During the past decade, Centrum Medyczne NeuroProtect conducted 41 clinical trials. In the 10-year time frame, 41 clinical trials started and 14 clinical trials were completed, i.e. on average, 34.1% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 14 clinical trials were completed. i.e. 58.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centrum Medyczne NeuroProtect" #1 sponsor was "Hoffmann-La Roche" with 11 trials, followed by "Eli Lilly and Company" with 5 trials sponsored, "Biogen" with 3 trials sponsored, "Celgene" with 3 trials sponsored and "Genentech, Inc." with 3 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centrum Medyczne NeuroProtect" #1 collaborator was "AbbVie" with 1 trials as a collaborator, "Denali Therapeutics Inc." with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Prothena Biosciences Limited" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Centrum Medyczne NeuroProtect" are "Alzheimer's Disease" (10 trials), "Alzheimer Disease" (8 trials), "Multiple Sclerosis" (5 trials), "Amyotrophic Lateral Sclerosis" (3 trials) and "Parkinson Disease" (3 trials). Many other conditions were trialed in "Centrum Medyczne NeuroProtect" in a lesser frequency.

Most popular intervention types in "Centrum Medyczne NeuroProtect" are "Drug" (42 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (22 trials), "Ocrelizumab" (5 trials), "Crenezumab" (3 trials), "AVP-786" (2 trials) and "Antihistamine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Centrum Medyczne NeuroProtect" are 42 trials for "All" genders.

Currently, there are NaN active trials in "Centrum Medyczne NeuroProtect". undefined are not yet recruiting, 13 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Centrum Medyczne NeuroProtect, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Centrum Medyczne NeuroProtect, 0 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".